Produktname:5-Morpholinopyrimidine-2,4(1H,3H)-dione

IUPAC Name:5-(morpholin-4-yl)-1,2,3,4-tetrahydropyrimidine-2,4-dione

CAS:37454-52-7
Molekulare Formel:C8H11N3O3
Reinheit:95%
Katalognummer:CM121239
Molekulargewicht:197.19

Packungseinheit Verfügbarer Vorrat Preis($) Menge
CM121239-1g 1-2 Weeks ȌƤɐ

Nur für den Einsatz in Forschung und Entwicklung..

Anfrage-Formular

   refresh    

Produkt-Details

CAS-Nr.:37454-52-7
Molekulare Formel:C8H11N3O3
Schmelzpunkt:-
SMILES-Code:O=C1NC(C(N2CCOCC2)=CN1)=O
Dichte:
Katalognummer:CM121239
Molekulargewicht:197.19
Siedepunkt:
Mdl-Nr.:MFCD00233546
Lagerung:

Category Infos

Morpholines
Morpholine contains secondary amine groups and has all the typical reactive characteristics of secondary amine groups. It can react with inorganic acids to form salts, and react with organic acids to form salts or amides, which can be subjected to alkylation reaction, and can also be reacted with ethylene oxide, ketone or Willgerodt reaction. Morpholine is a six-membered ring containing oxygen and nitrogen, and its alkalinity is much lower than that of its parent piperidine. The marketed morpholine drugs are mainly distributed in the fields of tumors, cardiovascular and cerebrovascular diseases, respiratory system diseases, digestive system diseases, infectious diseases and mental disorders.
morpholine price
if you are interested in morpholine price, please feel free to contact us. More information of our products will be forwarded to you upon receipt of your specific inquiry.
Pyrimidines
Pyrimidine, also known as 1,3-diazobenzene, is a heterocyclic compound with the chemical formula C4H4N2. Pyrimidine is formed by substituting 2 nitrogen atoms for 2 carbons in the meta-position of benzene. It is a diazine and retains its aromaticity. Derivatives of pyrimidine widely exist in organic macromolecular nucleic acids, and many drugs also contain pyrimidine rings. In nucleic acids, three nucleobases are pyrimidine derivatives: cytosine, thymine and uracil. There are a variety of pyrimidine-containing drugs on the market, most of which are kinase inhibitors.

Column Infos